Jae Man Lee

Title: Innovations of Jae Man Lee in Phospholipid Research

Introduction

Jae Man Lee is an accomplished inventor based in Houston, TX (US). She has made significant contributions to the field of biochemistry, particularly in the study of phospholipids and their applications in treating metabolic disorders.

Latest Patents

Jae Man Lee holds a patent for "Phospholipid compositions and uses thereof." This invention highlights the discovery that phospholipids diundecanoyl (C11:0-C11:0) and dilauroyl (C12:0-C12:0) phosphatidylcholine (PC) act as agonists of the LRH-1 receptor. The research demonstrates that administering these lipids to diabetic mice effectively reduces blood glucose levels. The patent features compositions that include these lipids and structurally related lipids, along with methods for treating metabolic disorders and inflammatory bowel disease, lowering blood glucose levels, and increasing LRH-1 receptor activity in subjects.

Career Highlights

Jae Man Lee is affiliated with Baylor College of Medicine, where she conducts her research. Her work has garnered attention for its potential impact on diabetes treatment and metabolic health.

Collaborations

Jae Man Lee collaborates with David D Moore, who is also involved in research related to her work. Their partnership enhances the exploration of phospholipid applications in medical science.

Conclusion

Jae Man Lee's innovative research in phospholipid compositions represents a significant advancement in the field of metabolic disorder treatment. Her contributions are paving the way for new therapeutic approaches to managing diabetes and related conditions.